As per Future Market Insights’ latest industry analysis, the valuation of the global cell therapy manufacturing market was around US$ 3.3 Bn in 2021, and is projected to exhibit a CAGR of close to 14.2% over the forecast period. The market is expected to reach US$ 13.9 Bn in 2032. Cell therapies are utilized widely to treat viral infections, cancer, hemoglobinopathies, and hereditary immunological disorders. Introduction of …
Category Archives: Healthcare Trends
Disposable Endoscopes Market is likely to reach a valuation of US$ 5.3 billion by 2032 | Exclusive Report by FMI
As per Future Market Insights’ latest analysis, valuation of the global disposable endoscopes market was around US$ 909.9 Million in 2021. The market is projected to exhibit a CAGR of close to 17.6% from 2022 to 2032 and reach an estimated valuation of around US$ 5.3 Billion in 2032. Endoscope-related infections can be differentiated into endogenous and exogenous. Presence of microbes that have the ability …
Laband Syndrome Therapeutics Market Share 2023 to 2033 | By SI Group, Selleckchem, BASF, Merck, Takeda
According to a recent FMI report, the global Laband Syndrome Therapeutics market demand will develop at a compound annual growth rate (CAGR) of 5.2% between 2023 and 2033. According to the report, the market will be worth US$ 5 billion by the end of the evaluation period. There is a growing public awareness of rare …
Alcohol Use Disorder Treatment Market Size 2023 to 2033 | By BioCorRx, Merck, Alkermes, Omeros
According to a recent FMI analysis, the worldwide Alcohol Use Disorder Treatment market demand is expected to grow at a 6.4% CAGR from 2023 to 2033. The market is anticipated to be valued at US$ 1300 million by the end of the evaluation period. The increasing number of drug awareness campaigns, prevention programmes, and technology …
Dengue Fever Treatment Market Growth 2023 to 2033 | By Perrigo, ABIVAX, Mylan N.V, Pfizer, Sanofi
The global Dengue Fever Treatment Market size is expected to be worth US$ 877.82 million in 2023 and US$ 5435.25 million by 2033, with a CAGR of 20% from 2023 to 2033. Dengue Fever Therapy market expanded at an 11% CAGR between 2018 and 2022. Dengue fever has increased rapidly in recent decades, according to …
Drug Eruptions Treatment Market Share 2023 to 2033 | By Astellas Pharma, Sanofi, Novartis AG, APOTEX, SBH Sciences
In fiscal year 2023, the global Drug Eruptions Treatment Market revenue is expected to be worth US$ 3.89 billion, up from US$ 3.66 billion in fiscal year 2022. The global market is expected to grow at a 6.2% CAGR from 2023 to 2033, reaching US$ 7.1 billion by the end of that year. A drug …
Edward’s Syndrome Treatment Market Size 2023 to 2033 | By Pfizer, Bellus Health, Sanofi, Merck, Bayer AG
The Edward’s Syndrome Treatment Market demand is expected to grow at a 5% CAGR between 2023 and 2033, according to Future Market Insights. The global market for Edward’s Syndrome Treatment is expected to reach US$ 7.98 billion by 2033. The market’s growth can be attributed to technical advancements in diagnostic testing and the development of …
Fucosidosis Therapeutics Market is expected to reach US$ 17.91 Million by 2033, at a CAGR of 6%
With a CAGR of 6% from 2023 to 2033, the global Fucosidosis Therapeutics Market sales is anticipated to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033. The Fucosidosis Therapeutics market increased at a 4% CAGR between 2018 and 2022. According to studies, fucosidosis is a rare autosomal recessive lysosomal storage …
Filariasis Treatment Market Share 2023 to 2033 | By AbbVie, Elsai, Cipla, Pfizer, Novartis AG
According to Future Market Insights, the global Filariasis Treatment Market demand will develop at a 10.1% compound annual growth rate (CAGR) between 2023 and 2033, reaching a value of US$ 28.68 billion by 2033. The rising prevalence of filariasis, enhanced diagnostic capabilities, and increased awareness of the disease are projected to fuel market expansion. Furthermore, …
Swab and Viral Transport Medium Market is projected to register a 5.8% CAGR and top a valuation of US$ 15.60 billion by 2033
The global Swab and Viral Transport Medium Market may exceed US$ 8.86 billion in 2023, according to a recent market analysis by FMI. According to FMI’s prediction, the market might expand at a 5.8% CAGR and reach a value of $15.60 billion by 2033. Due to the COVID-19 outbreak, swabs and viral delivery mediums are …